PofoliaShared via Pofolia

Retina· 2012Q1

IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV)

Lawrence A. Yannuzzi, John A. Sorenson, Richard F. Spaide, Barry K. Lipson

Short summary

Idiopathic polypoidal choroidal vasculopathy (IPCV), a distinct macular disorder characterized by polypoidal vascular lesions leading to hemorrhagic and exudative macular degeneration, has been identified and named.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Idiopathic polypoidal choroidal vasculopathy (IPCV) is a newly identified macular disorder.
  • IPCV is characterized by polypoidal, subretinal, vascular lesions.
  • These lesions lead to hemorrhagic and exudative macular degeneration with serous and hemorrhagic detachments of the retinal pigment epithelium.
  • IPCV differs clinically and demographically from age-related macular degeneration (AMD).

AI-generated from the title and abstract; the full text is not read.

Abstract

Eleven patients, 40 to 71 years old, had a choroidal vasculopathy that led to hemorrhagic and exudative macular degeneration. The patients had peculiar polypoidal, subretinal, vascular lesions associated with serous and hemorrhagic detachments of the retinal pigment epithelium. This macular disorder, which we have named idiopathic polypoidal choroidal vasculopathy (IPCV), appears to represent a distinct entity that differs clinically and demograph-ically from age-related macular degeneration (AMD) and other macular diseases associated with subretinal neovascularization. Recognition of this condition is important because it may have specific risk factors, natural course, and management considerations that differ from those of age-related macular degeneration

The authors' abstract, as published at the source. Retina, 2012 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Ophthalmology

OphthalmologyMedicine